Khalifa Economic Zones Abu Dhabi – Kezad Group will showcase the competitive advantages that Abu Dhabi offers to researchers, manufacturers and distributors focused on Arab Health 2023.
As the premier life science economic zone in the MENA region, Kezad already has many pharmaceutical manufacturers, life science enterprises, laboratories, packaging enterprises and supporting services, including Hope Consortium, ADCAN Pharma, Neopharma, Medisal and many other leading institutions, national reference Laboratories and Pharmatrade, including G42 announced last year to develop one of the largest vaccine production facilities in Kezad.
Kezad Group will demonstrate its ability to support industry growth and innovation through a life science ecosystem in the heart of Abu Dhabi, designed for manufacturing, logistics, development and education activities in the field.
Life Science Ecosystem
Kezad’s healthcare and life sciences ecosystem currently covers 1.6 square kilometers and is supported by intermodal connectivity by land, sea, air and soon to be rail, through a range of solutions including service land and diversification The company offers custom facilities with fast setup times, as well as key storage options offering standard, cold storage and cold storage solutions.
Strengthening the government’s efforts to position the country as a regional hub for pharmaceutical manufacturing, the ecosystem also benefits from strong institutional support to facilitate expedited licensing, licensing and product registration.
Khalifa Economic Zones Abu Dhabi – Kezad Group CEO Mohamed Al Khadar Al Ahmad said: “At Arab Health 2023, Kezad Group will share its unique value proposition to accelerate growth and innovation in the healthcare sector in the region. As industry and manufacturing A leading enabler of the industry, Kezad Group currently supports the operations of leading healthcare companies through its Life Sciences Centre.
Cold chain storage
In addition to critical infrastructure, such as advanced cold chain storage and blockchain management for safe and secure vaccine distribution, Kezad Group also provides unparalleled multimodal connectivity, linking healthcare operations to global markets, serving approximately 4.5 billion worldwide people provide services. “
A major demonstration of Kezad’s capabilities in the field is its key role as part of the UAE-based HOPE alliance, which has facilitated the global distribution of millions of Covid-19 vaccines. AD Ports Group has commissioned 19,000 square meters of refrigerated warehouse space within the project area, capable of storing over 120 million doses of Covid-19 vaccines, and continues to expand the life-saving medicines facility. — trade arab news agency